New Device Aims to Measure Brain's Waste-Clearing System During Sleep
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
20 articles
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
Stanford researchers find pioglitazone and liraglutide improve CNS insulin signaling, measured via neuron-derived vesicles in blood.
Transdermal alcohol monitors paired with machine learning can now detect drinking events with over 90% accuracy β a leap beyond flawed self-reports.
New research reveals how glucose availability directs brain cell proliferation via a metabolic-epigenetic axis, with implications for MS and brain repair.
A landmark review proposes a paradigm shift in neurocritical care, moving from static ICP thresholds to dynamic intracranial monitoring of autoregulation, glymphatics, and compliance.
MethylCog, a 29-CpG blood test, indexes general cognitive ability and improves mild cognitive impairment detection beyond age and sex alone.
New study combines smartphone sensors, brain scans, and daily check-ins to predict suicide risk in vulnerable patients.
A Phase 3 trial investigates whether the GLP-1 drug liraglutide can slow cognitive decline in T2DM patients at elevated Alzheimer's risk.
AI framework Reti-Pioneer screens for seven systemic diseases from a retinal photo, outperforming standard lab tests in speed and accuracy.
New NIH research reveals the brain-cell signaling mechanism behind GLP-1 drug plateaus and a potential way to extend their effects.
Emergency case study shows how brain imaging helps diagnose life-threatening metabolic crisis in alcohol-related emergency.
Dr. Gabrielle Lyon explains the metabolic science behind carb limits and why timing matters more than total daily intake.
A new study warns that diabetes medications could confound Alzheimer's biomarker studies, distorting our understanding of the diabetes-dementia link.
A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.
Board-certified surgeon reveals how to become CEO of your own biology using simple biomarkers and preventive health strategies.
A cohort of 18,000+ children and adults self-reported seizure durations, revealing patterns that could reshape clinical tracking and care.
A take-home brain-computer interface restored daily communication and control for a man with motor neuron disease, marking a milestone in neurotechnology.
Revolutionary Wave-CAIPI technology dramatically reduces brain scan time while maintaining accuracy for monitoring Alzheimer's treatments.
A completed RCT tested whether a CBT-based smartphone app reduces moderate depression versus an active placebo in 158 participants; outcomes are not reported in the registration record.
People with mild cognitive impairment recruit extra brain regions and show altered muscle control just to stay balanced while thinking.